ALNY, LTH & ZETA - The momentum may drive prices to new heights!

76
Alnylam Pharmaceuticals
  • The stock price has encountered several rejections around the 212 level, leading to subsequent corrections.
  • After establishing a Double Bottom pattern, the price attempted to reverse the downward trend but was unable to do so, facing rejection at the 200 level.
  • Consequently, the stock underwent another correction.
  • Following this, the price entered a consolidation phase, forming a Box pattern for a while.
  • In a surprising turn, the price gapped up significantly and broke through its former strong resistance area, remaining above it.
  • Following a brief pullback, the price resumed its upward trajectory, supported by solid trading volume.


snapshot
Life Time Group Holdings
  • Following a rejection around the 22.5 level in November 2021, the stock experienced a significant decline, dropping to just 8.75.
  • Subsequently, the price began to rise again, eventually returning to its previous strong resistance level after a lengthy climb. However, it struggled to break through that barrier and faced another substantial drop.
  • During this downturn, the stock hit a low around 11.3 and then navigated through numerous fluctuations, leading to the formation of a Symmetrical Triangle pattern on the chart.
  • After successfully breaking out of this pattern to the upside, the price surged and managed to overcome the resistance level.
  • If the stock can hold onto this level, we might see even more upward momentum in the days ahead.


snapshot
Zeta Global Holdings
  • The stock price had been consolidating within a Box Pattern before breaking free.
  • Since that breakout, the stock has experienced a steady uptrend, marked by higher highs and higher lows.
  • Amid this upward movement, a Cup & Handle pattern formed, signaling that the trend is likely to persist.
  • Following the breakout, the price is now climbing higher, supported by a significant increase in trading volume.

Clause de non-responsabilité

Les informations et les publications ne sont pas destinées à être, et ne constituent pas, des conseils ou des recommandations en matière de finance, d'investissement, de trading ou d'autres types de conseils fournis ou approuvés par TradingView. Pour en savoir plus, consultez les Conditions d'utilisation.